Anti-Proteasome 19S S5A/ASF antibody [EPR8936]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal Proteasome 19S S5A/ASF antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 7 publications.
View Alternative Names
MCB1, PSMD4, 26S proteasome non-ATPase regulatory subunit 4, 26S proteasome regulatory subunit RPN10, 26S proteasome regulatory subunit S5A, Antisecretory factor 1, Multiubiquitin chain-binding protein, AF, ASF
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Proteasome 19S S5A/ASF antibody [EPR8936] (AB137109)
Intracellular flow cytometric analysis of permeabilized K562 cells labelling Proteasome 19S S5A/ASF with ab137109 at 1/100 dilution (red). Negative Rabbit IgG control shown in green.
- WB
Unknown
Western blot - Anti-Proteasome 19S S5A/ASF antibody [EPR8936] (AB137109)
All lanes:
Western blot - Anti-Proteasome 19S S5A/ASF antibody [EPR8936] (ab137109) at 1/1000 dilution
Lane 1:
Jurkat cell lysate at 10 µg
Lane 2:
K562 cell lysate at 10 µg
Lane 3:
HepG2 cell lysate at 10 µg
Lane 4:
C6 cell lysate at 10 µg
Lane 5:
Raw264.7 cell lysate at 10 µg
Lane 6:
PC-12 cell lysate at 10 µg
Lane 7:
NIH/3T3 cell lysate at 10 µg
Secondary
All lanes:
HRP-labelled Goat anti-Rabbit at 1/2000 dilution
Predicted band size: 40 kDa
false
Related conjugates and formulations (1)
-
Anti-Proteasome 19S S5A/ASF antibody [EPR8936] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The 19S S5A operates as part of a larger proteasome complex involved in maintaining protein homeostasis. It ensures efficient degradation of ubiquitinated proteins by the 26S proteasome system playing a role in cell cycle regulation signal transduction and stress responses. The S5A subunit specifically binds ubiquitin regulating the availability of substrates subject to proteolysis which is critical for the timely removal of damaged or misfolded proteins and the regulation of various intracellular processes.
Pathways
The 19S S5A participates in the ubiquitin-proteasome pathway which is critical for protein turnover and quality control in cells. It interacts with proteins such as E3 ubiquitin ligases which tag substrates with ubiquitin chains for degradation. This process is also a part of the NF-kB signaling pathway where the proteasome degrades IκB proteins leading to the activation of NF-kB and modulation of immune responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Human cell 36:1755-1772 PubMed37336868
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 297:101275 PubMed34619150
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular & cellular proteomics : MCP 19:1281-1302 PubMed32434922
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 10:644 PubMed31501420
2019
Applications
Unspecified application
Species
Unspecified reactive species
Gene 702:66-74 PubMed30930224
2019
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of 112:11229-34 PubMed26305948
2015
Applications
Unspecified application
Species
Unspecified reactive species
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 41:896-905 PubMed26202105
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com